|
|
|
|
||
Re: Mirv -- Most promising clinical canidateNo you are right about that Gary. Bob Lutz was a VP at IMGN for 23 yrs. John Lambert was the Chief Scientific Officer and was instrumental in getting this company off the ground. Stock price looks to me…hows that saying go? Darkest night just before Dawn? Should turn soon. Support at $4.50. |
return to message board, top of board |